Invicta Diagnos.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0XJ501010
  • NSEID: INVICTA
  • BSEID:
INR
70.00
7 (11.11%)
BSENSE

Apr 01

BSE+NSE Vol: 8000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.0 k (-85.71%) Volume

Shareholding (Dec 2025)

FII

0.94%

Held by 1 FIIs

DII

10.22%

Held by 0 DIIs

Promoter

66.70%

Why is Invicta Diagnostic Ltd falling/rising?

01-Apr-2026

As of 31-Mar, Invicta Diagnostic Ltd's stock price is at 63.00, down 3.08% and significantly underperforming compared to the Sensex. The stock has declined 20.55% year-to-date and is trading below all moving averages, indicating a bearish trend despite increased investor participation.

As of 31-Mar, Invicta Diagnostic Ltd's stock price is falling, currently at 63.00, reflecting a decrease of 2.0 points or 3.08%. This decline is evident in the stock's performance over various periods, with a 1-week drop of 6.67% compared to a minor decline of 0.81% in the Sensex. Additionally, the year-to-date performance shows a significant decrease of 20.55% for Invicta, while the Sensex has fallen by 14.54%.<BR><BR>Today's trading performance indicates that the stock has underperformed its sector by 1.2%. Furthermore, Invicta Diagnostic Ltd is trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bearish trend. <BR><BR>Despite a rise in investor participation, with delivery volume increasing by 62.5% on 27 March compared to the 5-day average, the overall market sentiment appears negative, contributing to the stock's decline. The liquidity of the stock remains adequate for trading, but the prevailing downward trend in price indicates that investor confidence may be waning.

View full answer

Which are the latest news on Invicta Diagnos.?

01-Apr-2026
No latest news for Invicta Diagnos. found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 79 Cr (Micro Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.03

stock-summary
Return on Equity

27.87%

stock-summary
Price to Book

4.71

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.56%
0%
-9.56%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Invicta Diagnos. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
5.93
Debt to EBITDA (avg)
0.37
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.10
Tax Ratio
24.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.16%
ROCE (avg)
29.47%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
17
Industry P/E
0
Price to Book Value
4.71
EV to EBIT
12.07
EV to EBITDA
8.74
EV to Capital Employed
4.82
EV to Sales
2.62
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
39.90%
ROE (Latest)
27.87%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
KST
Dow Theory
Mildly Bullish
OBV
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.94%)

Promoter with highest holding

Badal Kailash Naredi (11.07%)

Highest Public shareholder

Rajasthan Global Securities Private Limited (4.48%)

Individual Investors Holdings

18.49%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Invicta Diagnos."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Invicta Diagnos."
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Invicta Diagnos."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Invicta Diagnos."
  }
]
stock-summaryCompany CV
About Invicta Diagnostic Ltd stock-summary
stock-summary
Invicta Diagnostic Ltd
Micro Cap
Healthcare Services
Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name "Invicta Diagnostic LLP" vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre. Further, Invicta Diagnostic LLP converted into a Private Limited Company as "Invicta Diagnostic Private Limited" dated December 01, 2023.
Company Coordinates stock-summary
Icon
No Company Details Available